Fingerprint
Dive into the research topics of 'Phase II trial of erlotinib and bevacizumab in patients with advanced upper gastrointestinal cancers'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase II trial of erlotinib and bevacizumab in patients with advanced upper gastrointestinal cancers
Kristoffer S Rohrberg, René K Olesen, Per Pfeiffer, Morten Ladekarl, Helle Pappot, Ib J Christensen, Gunilla Høyer-Hansen, Morten Sørensen, Birgit G Skov, Ian Buysschaert, Peter Carmeliet, Ulrik Lassen